Pretreatment serum levels of tumor associated trypsin inhibitor (TATI) in180 gynecological and surgical cancer patients, a comparison with other modenr and classical tumor markers

C.A. Yedema; P. Kenemans; Th. Wobbes; E. op 't Rood; RHM Verheijen; L.G. Poels; C.M.G. Thomas

Pretreatment serum levels of tumor associated trypsin inhibitor (TATI) in180 gynecological and surgical cancer patients, a comparison with other modenr and classical tumor markers

C.A. Yedema, P. Kenemans, Th. Wobbes, E. op 't Rood, RHM Verheijen, L.G. Poels, C.M.G. Thomas

Research output: Contribution to conference › Abstract › Other research output

Original language	English
Publication status	Published - 1987
Event	II International Symposium on Biology and Clinical Usefulness of Tumor Markers - Barcelona, Spain Duration: 6 Apr 1987 → …

Conference

Conference	II International Symposium on Biology and Clinical Usefulness of Tumor Markers
Country/Territory	Spain
City	Barcelona
Period	6/04/87 → …

Cite this

Yedema, C. A., Kenemans, P., Wobbes, T., op 't Rood, E., Verheijen, RHM., Poels, L. G., & Thomas, C. M. G. (1987). Pretreatment serum levels of tumor associated trypsin inhibitor (TATI) in180 gynecological and surgical cancer patients, a comparison with other modenr and classical tumor markers. Abstract from II International Symposium on Biology and Clinical Usefulness of Tumor Markers, Barcelona, Spain.

@conference{656761e342614b06ae29e113215b8a9e,

title = "Pretreatment serum levels of tumor associated trypsin inhibitor (TATI) in180 gynecological and surgical cancer patients, a comparison with other modenr and classical tumor markers",

author = "C.A. Yedema and P. Kenemans and Th. Wobbes and {op 't Rood}, E. and RHM Verheijen and L.G. Poels and C.M.G. Thomas",

year = "1987",

language = "English",

note = "II International Symposium on Biology and Clinical Usefulness of Tumor Markers ; Conference date: 06-04-1987",

}

Yedema, CA, Kenemans, P, Wobbes, T, op 't Rood, E, Verheijen, RHM, Poels, LG & Thomas, CMG 1987, 'Pretreatment serum levels of tumor associated trypsin inhibitor (TATI) in180 gynecological and surgical cancer patients, a comparison with other modenr and classical tumor markers', II International Symposium on Biology and Clinical Usefulness of Tumor Markers, Barcelona, Spain, 6/04/87.

Pretreatment serum levels of tumor associated trypsin inhibitor (TATI) in180 gynecological and surgical cancer patients, a comparison with other modenr and classical tumor markers. / Yedema, C.A.; Kenemans, P.; Wobbes, Th. et al.
1987. Abstract from II International Symposium on Biology and Clinical Usefulness of Tumor Markers, Barcelona, Spain.

Research output: Contribution to conference › Abstract › Other research output

TY - CONF

T1 - Pretreatment serum levels of tumor associated trypsin inhibitor (TATI) in180 gynecological and surgical cancer patients, a comparison with other modenr and classical tumor markers

AU - Yedema, C.A.

AU - Kenemans, P.

AU - Wobbes, Th.

AU - op 't Rood, E.

AU - Verheijen, RHM

AU - Poels, L.G.

AU - Thomas, C.M.G.

PY - 1987

Y1 - 1987

M3 - Abstract

T2 - II International Symposium on Biology and Clinical Usefulness of Tumor Markers

Y2 - 6 April 1987

ER -

Yedema CA, Kenemans P, Wobbes T, op 't Rood E, Verheijen RHM, Poels LG et al.. Pretreatment serum levels of tumor associated trypsin inhibitor (TATI) in180 gynecological and surgical cancer patients, a comparison with other modenr and classical tumor markers. 1987. Abstract from II International Symposium on Biology and Clinical Usefulness of Tumor Markers, Barcelona, Spain.